Atherosclerosis: An epigenetic balancing act that goes wrong

Current Atherosclerosis Reports

Volumn 13, Issue 3, 2011, Pages 208-214

  Lund, Gertrud ^a   Zaina, Silvio ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Alternative splicing; Diet; Inflammation; Nuclear receptors

Indexed keywords

HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMATIN ASSEMBLY AND DISASSEMBLY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FOOD INTAKE; GENE ACTIVATION; GENE FUNCTION; GENE REPRESSION; GENOME ANALYSIS; HISTONE MODIFICATION; HUMAN; LIFESPAN; NONHUMAN; PROMOTER REGION; REVIEW; TRANS SPLICING; TRANSCRIPTION REGULATION; VITAMIN DEFICIENCY;

ANIMALS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DIETARY FATS; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENOMICS; GENE EXPRESSION REGULATION; GENE SILENCING; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; LIFE STYLE; LIPID METABOLISM; MODELS, BIOLOGICAL; PHENOTYPE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RISK ASSESSMENT;

EID: 79955928265     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-011-0174-3     Document Type: Review

References (50)

1. The global burden of disease: 2004 update. WHO; 2008.
2. Stevens G, Dias RH, Thomas KJA, et al. Characterizing the epidemiological transition inMexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008;5:e125.
3. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science. 2010;330:612-6.
4. Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet. 2010;70:101-41.
5. Berstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 2007;128:669-81. (Pubitemid 46273573)
6. Nicolaou G, Erridge C. Toll-like receptor-dependent lipid body formation in macrophage foam cell formation. Curr Opin Lipidol. 2010;21:427-33.
7. Newman PE. Can reduced folic acid and vitamin B12 cause deficient DNA methylation producing mutations which initiate atherosclerosis? Med Hypotheses. 1999;53:421-4.
8. Mangoni AA. Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials? Clin Chim Acta. 2006;367:11-9.
9. Laukkanen MO, Mannermaa S, Hiltunen MO, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol. 1999;19:2171-8. (Pubitemid 29422250)
10. Hiltunen MO, Turunen MP, Häkkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med. 2002;7:5-11. (Pubitemid 34654067)
11. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem. 2004;279:29147-54. (Pubitemid 38915787)
12. Castillo-Díaz SA, Garay-Sevilla ME, Hernández- González MA, Solís-Martínez MO, Zaina S. Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries. Int J Mol Med. 2010;26:691-700.
13. Bird A, Taggart M, Frommer M, Miller OJ, Macleod D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell. 1985;40:91-9.
14. KimM, Arakawa K,Wang R, et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS ONE. 2010;5:e9692.
15. Post WS, Goldschmidt-Clermont PJ, Willhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999;43:985-91. (Pubitemid 29413198)
16. Zhu S, Goldschmidt-Clermont PJ, Dong C. Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation. 2005;112:1353-61. (Pubitemid 41266732)
17. Devlin AM, Singh R, Wade RE, et al. Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J Biol Chem. 2007;282:37082-90.
18. Zawadzki C, Chatelain N, Delestre M, et al. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis. 2009;204:e4-14.
19. Barrès R, Osler ME, Yan J, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009;10:189-98. This is the first direct demonstration that a pro-inflammatory fatty acid is capable of inducing global DNA methylation changes.
20. Hansen AE. Role of dietary fat in human nutrition. I. Role of unsaturated dietary fat in infant nutrition. Am J Public Health Nations Health. 1957;47:1367-70.
21. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23:5293-300. (Pubitemid 36950884)
22. Massiera F, Barbry P, Guesnet P, et al. A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res. 2010;51:2352-61.
23. Lycko F, Foret S, Kucharski R, et al. The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol. 2010;8:e1000506. This is a genome-wide analysis of diet-specific DNA methylation patterns in honeybees. Intragenic sequences represent a significant portion of differentially methylated sequences, which is likely to underlie differential transcript splicing profiles.
24. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008;319:1827-30. This article is a demonstration that a differential dietary regime is associated with specific DNA methylation patterns.
25. Yang TP, Agellon LB, Walsh A, Breslow JL, Tall AR. Alternative splicing of the human cholesteryl ester transfer protein gene in transgenic mice. Exon exclusion modulates gene expression in response to dietary or developmental change. J Biol Chem. 1996;271:12603-9. (Pubitemid 26160935)
26. Dessí M, Motti C, Cortese C, et al. Alternative splicing of human plasma cholesteryl ester transfer protein mRNA in Caco-2 cells and its modulation by oleic acid. Mol Cell Biochem. 1997;177:107-12. (Pubitemid 27522364)
27. Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr. 2010;30:315-39.
28. Mukherjee S. Adult onset atherosclerosis may have its origin in the foetal state in utero. Curr Opin Lipidol. 2009;20:155-6.
29. Huang W, Glass CK. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol. 2010;30:1542-9.
30. Welsh JS, Ricote M, Akiyama TE, et al. PPAR gamma and PPAR delta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. PNAS. 2003;100:6712-7. (Pubitemid 36666645)
31. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPAR gamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116-20. (Pubitemid 47014427)
32. Babaev VR, Yancey PG, Ryzhov SV, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:1647-53. (Pubitemid 41098935)
33. Regieli JJ, Jukema JW, Doevendans PA, et al. PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients. Diab Care. 2009;32:839-44.
34. Kanda T, Brown JD, Orasanu G, et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest. 2009;119:110-24.
35. Schupp M, Lazar MA. Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem. 2010 Oct 18, [Epub ahead of print].
36. Spencer NF, Poynter ME, Im SY, Daynes RA. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol. 1997;9:1581-8. (Pubitemid 27434691)
37. Stein S, Lohmann C, Handschin C, et al. ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis. PLoS One. 2010;5:13539. This is a demonstration of the dual activity of PPARs. Co-activator PPAR partners can exert pro-inflammatory effects in addition to the well-established repressive activity of PPARs on NF-κB and other inflammation markers.
38. Zhang Y, Luo Z, Ma L, et al. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med. 2010;25:729-34.
39. Rahman M, Halade GV, Bhattacharya A, Fernandes G. The fat-1 transgene in mice increases antioxidant potential, reduces proinflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet. Oxid Med Cell Longev. 2009;2:307-16.
40. Maloney E, Sweet IR, Hockenbery DM, et al. Activation of NFkappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol. 2009;29:1370-5.
41. Coll T, Palomer X, Blanco-Vaca F, et al. Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells. Endocrinology. 2010;151:537-48. This is a demonstration that distinct fatty acids differentially regulate inflammation by activating specific and cross-talking pathways involving PPARs and TLR, respectively.
42. Narala VR, Adapala RK, Suresh MV, et al. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferatoractivated receptor-alpha agonist. J Biol Chem. 2010;285:22067-74.
43. Hamza MS, Pott S, Vega VB, et al. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis. Genes Dev. 2008;22:2953-67. This is an exhaustive mapping of PPAR binding site across the genome.
44. Nielsen, R, Pedersen TA, Hagenbeek D, et al. Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. PLoS. 2010;5:e13539. This is an exhaustive mapping of PPAR binding site across the genome, with additional focus on promoter targets.
45. Choi JK. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol. 2010;11:R70.
46. Choy MK, Movassagh M, Goh HG, et al. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. BMC Genomics. 2010;11:519.
47. Carpinteyro-Espín P, Jacinto-Ruíz S, Caballero-Vazquez P, Alvarado-Caudillo Y, Lund G, Rodríguez-Rios D, et al. Organomegaly and tumours in transgenic mice with targeted expression of HpaII methyltransferase in smooth muscle cells. Epigenetics. 2011;6 (in press).
48. Tartof KD, Bremer M. Mechanisms for the construction and developmental control of heterochromatin formation and imprinted chromosome domains. Dev Suppl. 1990;35-45.
49. Dupont C, Armant DR, Brenner CA. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009;27:351-7.
50. Kerkel K, Spadola A, Yuan E, et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet. 2008;40:904-8.